反応式
[NH:1]([C:3]1[CH:8]=[C:7]([C:9]2[CH:14]=[CH:13][CH:12]=[CH:11][CH:10]=2)[N:6]=[C:5]([CH3:15])[N:4]=1)[NH2:2].[C:16]1([CH3:26])[CH:21]=[CH:20][C:19]([C:22](=O)[CH2:23][CH3:24])=[CH:18][CH:17]=1>C(O)C>[CH3:15][C:5]1[N:4]=[C:3]([NH:1][N:2]=[C:22]([C:19]2[CH:20]=[CH:21][C:16]([CH3:26])=[CH:17][CH:18]=2)[CH2:23][CH3:24])[CH:8]=[C:7]([C:9]2[CH:14]=[CH:13][CH:12]=[CH:11][CH:10]=2)[N:6]=1参加物
4
実験手順
The title compound was prepared from 4-hydrazino-2-methyl-6-phenylpyrimidine (300 mg, 1.5 mmol) and 1-p-Tolyl-propan-1-one (174 μL, 1.05 mmol) in 3.0 mL of ethanol by a procedure similar to example 1, step 4 yielding 110 mg (22%) of a white solid. HPLC Purity: 96%.
出典と根拠
- ORDレコード
- ord-a4909e30ae9c4eb38b3b8ef8437c01bc
- 出典データセット
- uspto-grants-2012_10
- 特許番号
- US08288398B2
関連ノート
読み込み中…